Maxwell John T. 4
4 · Aquestive Therapeutics, Inc. · Filed Aug 19, 2020
Insider Transaction Report
Form 4
Maxwell John T.
SVP-Chief Financial Officer
Transactions
- Sale
Common Stock
2020-08-18$8.00/sh−3,000$24,000→ 150,614 total
Footnotes (1)
- [F1]The sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 16, 2020.